Vitamin B-Complex

Verify with FDA CVM →

31 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
31
Total Reports
22
Deaths Reported
7100.0%
Death Rate

Active Ingredients

Vitamin B-Complex

Administration Routes

UnknownIntravenousSubcutaneous

Species Affected

Dog 15
Cat 15
Horse 1

Most Affected Breeds

Domestic Shorthair 11
Chihuahua 2
Boxer (German Boxer) 2
Terrier - Bull - American Pit 1
Maltese 1
Terrier (unspecified) 1
Retriever - Labrador 1
Terrier - Yorkshire 1
Domestic Longhair 1
Pinscher - Miniature 1

Most Reported Reactions

Anorexia 13
Lethargy (see also Central nervous system depression in 'Neurological') 12
Death 12
Vomiting 10
Other abnormal test result NOS 10
Death by euthanasia 10
Leucocytosis NOS 9
Elevated alanine aminotransferase (ALT) 8
Hyperphosphataemia 7
Anaemia NOS 6
Pale mucous membrane 6
Elevated serum alkaline phosphatase (SAP) 6

Outcome Breakdown

Died
13 (41.9%)
Euthanized
9 (29.0%)
Ongoing
7 (22.6%)
Recovered/Normal
1 (3.2%)
Outcome Unknown
1 (3.2%)

Data Summary

Metric Value
Total adverse event reports 31
Reports involving death 22
Case-fatality rate (reported events) 7100.0%
Distinct species in reports 3
Distinct breeds in reports 19
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Vitamin B-Complex Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 31 adverse event reports referencing Vitamin B-Complex, including 22 reports in which the animal died — a 7100.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Vitamin B-Complex. Reported administration routes include Unknown, Intravenous, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Vitamin B-Complex reports are Dog (15 reports), Cat (15 reports), Horse (1 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (11), Chihuahua (2), Boxer (German Boxer) (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Vitamin B-Complex are Anorexia (13), Lethargy (see also Central nervous system depression in 'Neurological') (12), Death (12), Vomiting (10). Of the 31 reports with a coded outcome, Died is the leading category at 41.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Vitamin B-Complex.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial